nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.034	0.034	CbGpPWpGaD
Oxybutynin—CHRM5—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.029	0.029	CbGpPWpGaD
Oxybutynin—CHRM5—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0282	0.0282	CbGpPWpGaD
Oxybutynin—CHRM5—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0262	0.0262	CbGpPWpGaD
Oxybutynin—CHRM5—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0244	0.0244	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0239	0.0239	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0239	0.0239	CbGpPWpGaD
Oxybutynin—CHRM5—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0237	0.0237	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0236	0.0236	CbGpPWpGaD
Oxybutynin—CHRM5—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.022	0.022	CbGpPWpGaD
Oxybutynin—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0204	0.0204	CbGpPWpGaD
Oxybutynin—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0204	0.0204	CbGpPWpGaD
Oxybutynin—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0202	0.0202	CbGpPWpGaD
Oxybutynin—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0198	0.0198	CbGpPWpGaD
Oxybutynin—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0198	0.0198	CbGpPWpGaD
Oxybutynin—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0196	0.0196	CbGpPWpGaD
Oxybutynin—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0185	0.0185	CbGpPWpGaD
Oxybutynin—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0184	0.0184	CbGpPWpGaD
Oxybutynin—CHRM5—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0184	0.0184	CbGpPWpGaD
Oxybutynin—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0182	0.0182	CbGpPWpGaD
Oxybutynin—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0172	0.0172	CbGpPWpGaD
Oxybutynin—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0171	0.0171	CbGpPWpGaD
Oxybutynin—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0169	0.0169	CbGpPWpGaD
Oxybutynin—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0167	0.0167	CbGpPWpGaD
Oxybutynin—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0166	0.0166	CbGpPWpGaD
Oxybutynin—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0164	0.0164	CbGpPWpGaD
Oxybutynin—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0155	0.0155	CbGpPWpGaD
Oxybutynin—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0155	0.0155	CbGpPWpGaD
Oxybutynin—CHRM5—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0154	0.0154	CbGpPWpGaD
Oxybutynin—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0153	0.0153	CbGpPWpGaD
Oxybutynin—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0129	0.0129	CbGpPWpGaD
Oxybutynin—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0129	0.0129	CbGpPWpGaD
Oxybutynin—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0128	0.0128	CbGpPWpGaD
Oxybutynin—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0109	0.0109	CbGpPWpGaD
Oxybutynin—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0108	0.0108	CbGpPWpGaD
Oxybutynin—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0107	0.0107	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00904	0.00904	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00895	0.00895	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00878	0.00878	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00869	0.00869	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00573	0.00573	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00567	0.00567	CbGpPWpGaD
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0056	0.0056	CbGpPWpGaD
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00543	0.00543	CbGpPWpGaD
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00506	0.00506	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00481	0.00481	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00479	0.00479	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00467	0.00467	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00465	0.00465	CbGpPWpGaD
Oxybutynin—CHRM5—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00459	0.00459	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00435	0.00435	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00434	0.00434	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00419	0.00419	CbGpPWpGaD
Oxybutynin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0041	0.0041	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00407	0.00407	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00394	0.00394	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00393	0.00393	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00389	0.00389	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00383	0.00383	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00381	0.00381	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00379	0.00379	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00378	0.00378	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00368	0.00368	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00365	0.00365	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00356	0.00356	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00355	0.00355	CbGpPWpGaD
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00354	0.00354	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00354	0.00354	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00352	0.00352	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00338	0.00338	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00337	0.00337	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00333	0.00333	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0033	0.0033	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00328	0.00328	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00327	0.00327	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00324	0.00324	CbGpPWpGaD
Oxybutynin—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00323	0.00323	CbGpPWpGaD
Oxybutynin—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00322	0.00322	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00305	0.00305	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00304	0.00304	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00304	0.00304	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00301	0.00301	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00289	0.00289	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00288	0.00288	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00257	0.00257	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00256	0.00256	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00254	0.00254	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0025	0.0025	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0025	0.0025	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00249	0.00249	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00249	0.00249	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00246	0.00246	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00246	0.00246	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00246	0.00246	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00233	0.00233	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00232	0.00232	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00231	0.00231	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0023	0.0023	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00214	0.00214	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00213	0.00213	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00211	0.00211	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	0.00207	0.00207	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00206	0.00206	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.002	0.002	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00187	0.00187	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00187	0.00187	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00182	0.00182	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	0.00179	0.00179	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00169	0.00169	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00163	0.00163	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00162	0.00162	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00161	0.00161	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00147	0.00147	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00145	0.00145	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00145	0.00145	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00143	0.00143	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00141	0.00141	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00141	0.00141	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00139	0.00139	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00132	0.00132	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00132	0.00132	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00131	0.00131	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00131	0.00131	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00131	0.00131	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.0013	0.0013	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0013	0.0013	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00128	0.00128	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00128	0.00128	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00126	0.00126	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00119	0.00119	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00119	0.00119	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00119	0.00119	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00118	0.00118	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00111	0.00111	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00107	0.00107	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.001	0.001	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000961	0.000961	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00092	0.00092	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000917	0.000917	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000908	0.000908	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000836	0.000836	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000833	0.000833	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000825	0.000825	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000779	0.000779	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000777	0.000777	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000769	0.000769	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000757	0.000757	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000754	0.000754	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000747	0.000747	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000705	0.000705	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000703	0.000703	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000701	0.000701	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000696	0.000696	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000494	0.000494	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000492	0.000492	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000487	0.000487	CbGpPWpGaD
